403 related articles for article (PubMed ID: 14641821)
1. Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata.
Rajagopal S; Kumar RA; Deevi DS; Satyanarayana C; Rajagopalan R
J Exp Ther Oncol; 2003; 3(3):147-58. PubMed ID: 14641821
[TBL] [Abstract][Full Text] [Related]
2. Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer.
Islam MT; Ali ES; Uddin SJ; Islam MA; Shaw S; Khan IN; Saravi SSS; Ahmad S; Rehman S; Gupta VK; Găman MA; Găman AM; Yele S; Das AK; de Castro E Sousa JM; de Moura Dantas SMM; Rolim HML; de Carvalho Melo-Cavalcante AA; Mubarak MS; Yarla NS; Shilpi JA; Mishra SK; Atanasov AG; Kamal MA
Cancer Lett; 2018 Apr; 420():129-145. PubMed ID: 29408515
[TBL] [Abstract][Full Text] [Related]
3. Anticancer and immunostimulatory compounds from Andrographis paniculata.
Kumar RA; Sridevi K; Kumar NV; Nanduri S; Rajagopal S
J Ethnopharmacol; 2004 Jun; 92(2-3):291-5. PubMed ID: 15138014
[TBL] [Abstract][Full Text] [Related]
4. Andrographis paniculata extracts and major constituent diterpenoids inhibit growth of intrahepatic cholangiocarcinoma cells by inducing cell cycle arrest and apoptosis.
Suriyo T; Pholphana N; Rangkadilok N; Thiantanawat A; Watcharasit P; Satayavivad J
Planta Med; 2014 May; 80(7):533-43. PubMed ID: 24782229
[TBL] [Abstract][Full Text] [Related]
5. Andrographolide exhibits anti-invasive activity against colon cancer cells via inhibition of MMP2 activity.
Chao HP; Kuo CD; Chiu JH; Fu SL
Planta Med; 2010 Nov; 76(16):1827-33. PubMed ID: 20539971
[TBL] [Abstract][Full Text] [Related]
6. Andrographolide inhibits IFN-gamma and IL-2 cytokine production and protects against cell apoptosis.
Burgos RA; Seguel K; Perez M; Meneses A; Ortega M; Guarda MI; Loaiza A; Hancke JL
Planta Med; 2005 May; 71(5):429-34. PubMed ID: 15931581
[TBL] [Abstract][Full Text] [Related]
7. Andrographolide inhibits human hepatoma-derived Hep3B cell growth through the activation of c-Jun N-terminal kinase.
Ji L; Liu T; Liu J; Chen Y; Wang Z
Planta Med; 2007 Oct; 73(13):1397-401. PubMed ID: 17918040
[TBL] [Abstract][Full Text] [Related]
8. Andrographolide and analogues in cancer prevention.
Mishra SK; Tripathi S; Shukla A; Oh SH; Kim HM
Front Biosci (Elite Ed); 2015 Jan; 7(2):255-66. PubMed ID: 25553378
[TBL] [Abstract][Full Text] [Related]
9. Overview of pharmacological activities of
Dai Y; Chen SR; Chai L; Zhao J; Wang Y; Wang Y
Crit Rev Food Sci Nutr; 2019; 59(sup1):S17-S29. PubMed ID: 30040451
[No Abstract] [Full Text] [Related]
10. Effect of andrographolide and Kan Jang--fixed combination of extract SHA-10 and extract SHE-3--on proliferation of human lymphocytes, production of cytokines and immune activation markers in the whole blood cells culture.
Panossian A; Davtyan T; Gukassyan N; Gukasova G; Mamikonyan G; Gabrielian E; Wikman G
Phytomedicine; 2002 Oct; 9(7):598-605. PubMed ID: 12487323
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of new potent inhibitors of dengue virus NS5 proteinase from Andrographis paniculata supercritical extracts on in animal cell culture and in silico approaches.
Kaushik S; Dar L; Kaushik S; Yadav JP
J Ethnopharmacol; 2021 Mar; 267():113541. PubMed ID: 33152438
[TBL] [Abstract][Full Text] [Related]
12. Andrographolide Exhibits Anticancer Potential Against Human Colon Cancer Cells by Inducing Cell Cycle Arrest and Programmed Cell Death via Augmentation of Intracellular Reactive Oxygen Species Level.
Khan I; Khan F; Farooqui A; Ansari IA
Nutr Cancer; 2018 Jul; 70(5):787-803. PubMed ID: 29781715
[TBL] [Abstract][Full Text] [Related]
13. Andrographolide inhibits osteopontin expression and breast tumor growth through down regulation of PI3 kinase/Akt signaling pathway.
Kumar S; Patil HS; Sharma P; Kumar D; Dasari S; Puranik VG; Thulasiram HV; Kundu GC
Curr Mol Med; 2012 Sep; 12(8):952-66. PubMed ID: 22804248
[TBL] [Abstract][Full Text] [Related]
14. Anticancer activity of andrographolide semisynthetic derivatives.
Menon V; Bhat S
Nat Prod Commun; 2010 May; 5(5):717-20. PubMed ID: 20521534
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of C-12 dithiocarbamate andrographolide analogues as an anticancer agent.
Arsakhant P; Sirion U; Chairoungdua A; Suksen K; Piyachaturawat P; Suksamrarn A; Saeeng R
Bioorg Med Chem Lett; 2020 Jul; 30(14):127263. PubMed ID: 32527561
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor activities of andrographolide, a diterpene from Andrographis paniculata, by inducing apoptosis and inhibiting VEGF level.
Zhao F; He EQ; Wang L; Liu K
J Asian Nat Prod Res; 2008; 10(5-6):467-73. PubMed ID: 18464090
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic constituents from Andrographis paniculata induce cell cycle arrest in jurkat cells.
Geethangili M; Rao YK; Fang SH; Tzeng YM
Phytother Res; 2008 Oct; 22(10):1336-41. PubMed ID: 18546141
[TBL] [Abstract][Full Text] [Related]
18. Dehydroandrographolide, an iNOS inhibitor, extracted from Andrographis paniculata (Burm.f.) Nees, induces autophagy in human oral cancer cells.
Hsieh MJ; Lin CW; Chiou HL; Yang SF; Chen MK
Oncotarget; 2015 Oct; 6(31):30831-49. PubMed ID: 26356821
[TBL] [Abstract][Full Text] [Related]
19. [Advances in study on anti-tumor mechanism of andrographolide].
Qi CL; Wang LJ; Zhou XL
Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(20):2095-7. PubMed ID: 18306735
[TBL] [Abstract][Full Text] [Related]
20. Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors.
Mir H; Kapur N; Singh R; Sonpavde G; Lillard JW; Singh S
Cell Cycle; 2016; 15(6):819-26. PubMed ID: 27029529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
